Detalhe da pesquisa
1.
Multiple cardiotoxicities during osimertinib therapy.
J Oncol Pharm Pract
; : 10781552231164301, 2023 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36942434
2.
Investigating the efficacy of osimertinib and crizotinib in phase 3 clinical trials on anti-cancer treatment-induced cardiotoxicity: are real-world studies the way forward?
J Oncol Pharm Pract
; 29(3): 646-662, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35167392
3.
Smoking, Diabetes Mellitus, and Previous Cardiovascular Disease as Predictors of Anticancer Treatment-Induced Cardiotoxicity in Non-Small-Cell Lung Cancer: A Real-World Study.
Clin Lung Cancer
; 25(1): e35-e42, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37880075
4.
Management of COVID-19 in cancer patients receiving cardiotoxic anti-cancer therapy. Future recommendations for cardio-oncology.
Oncol Rev
; 15(1): 510, 2021 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33747366